Goldman Sachs’s Allergan Inc AGN Stock Holding History

Goldman Sachs’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,890,100	Closed	-$402M	–	7645
2014 Q4	$402M	Buy	1,890,100 +748,600	+66%	+$149M	0.13%	151
2014 Q3	$203M	Buy	1,141,500 +56,400	+5%	+$9.37M	0.06%	326
2014 Q2	$184M	Buy	1,085,100 +807,700	+291%	+$126M	0.06%	391
2014 Q1	$34.4M	Buy	277,400 +106,300	+62%	+$12.9M	0.01%	1326
2013 Q4	$19M	Buy	171,100 +62,300	+57%	+$5.95M	0.01%	1787
2013 Q3	$9.84M	Sell	108,800 -277,700	-72%	-$24.9M	﹤0.01%	2267
2013 Q2	$32.6M	Buy	+386,500	New	+$40.1M	0.01%	1180

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Goldman Sachs's AGN Position: Q1 2015 in Review

Goldman Sachs sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,321,139 shares — an estimated $281M sold.

Goldman Sachs first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $281M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Goldman Sachs reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 1,321,139 Allergan Inc shares in Q1 2015, an estimated $281M.
Goldman Sachs first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Goldman Sachs's Allergan Inc position peaked at $281M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.